SCHEMBL185647

SCHEMBL185647

CC(C)C(CC(N)=O)c1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.57
CYP2C19 P33261 3/20 0.49
CYP1A2 P05177 1/20 0.46
CYP2D6 P10635 1/20 0.46
PKM P14618 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
ALOX5 P09917 1/20 0.46
ALDH1A1 P00352 1/20 0.45
SLC6A3 Q01959 5/20 0.44
DRD3 P35462 2/20 0.44
LMNA P02545 1/20 0.44
ADORA3 P0DMS8 1/20 0.44
EDNRB P24530 1/20 0.44
MAPK1 P28482 1/20 0.44
MC4R P32245 1/20 0.44
MC3R P41968 1/20 0.44
PLA2G1B P04054 1/20 0.44
ATG4B Q9Y4P1 1/20 0.44
DRD2 P14416 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1234229 0.84 TAAR1 (0.55) TAAR1CYP2C19CYP2D6PKMLMNA
SCHEMBL25152144 0.84 TAAR1 (0.55) TAAR1CYP2C19CYP2D6PKMLMNA
SCHEMBL17050186 0.84 TAAR1 (0.55) TAAR1CYP2C19CYP2D6SLC6A3PLA2G1B
SCHEMBL25152385 0.84 TAAR1 (0.55) TAAR1CYP2C19CYP2D6PKMLMNA
SCHEMBL12304083 0.83 CYP2C19 (0.50) TAAR1CYP2C19SMN1; SMN2ALOX5ALDH1A1
SCHEMBL11017601 0.82 SLC6A3 (0.50) CYP2C19CYP1A2CYP2D6PKMSMN1; SMN2
SCHEMBL10247979 0.82 TAAR1 (0.53) TAAR1ALDH1A1SLC6A3PLA2G1BATG4B
SCHEMBL26724801 0.82 TAAR1 (0.53) TAAR1ALDH1A1SLC6A3PLA2G1BATG4B
SCHEMBL12836118 0.81 AOC3 (0.42) ALDH1A1LMNA
SCHEMBL12836116 0.81 CYP2C9 (0.50) CYP2C19CYP1A2CYP2D6SMN1; SMN2DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108752241-A Acyl group guanidine for treating arthropathy 默克专利股份公司 2018-11-06 CN claimed
CN-105517993-B Aryl amide kinase inhibitors 百时美施贵宝公司 2018-07-13 CN claimed
EP-2401260-A1 DIOXO-IMIDAZOLIDINE DERIVATIVES, WHICH INHIBIT THE ENZYME SOAT-1, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM Galderma Research & Development (FR) 2012-01-04 EP claimed
WO-2010097465-A1 DIOXO-IMIDAZOLIDINE DERIVATIVES, WHICH INHIBIT THE ENZYME SOAT-1, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM GALDERMA RESEARCH & DEVELOPMENT (FR) 2010-09-02 WO claimed
CN-108752241-A Acyl group guanidine for treating arthropathy 默克专利股份公司 2018-11-06 CN disclosed
CN-105517993-B Aryl amide kinase inhibitors 百时美施贵宝公司 2018-07-13 CN disclosed
EP-2401260-A1 DIOXO-IMIDAZOLIDINE DERIVATIVES, WHICH INHIBIT THE ENZYME SOAT-1, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM Galderma Research & Development (FR) 2012-01-04 EP disclosed
WO-2010097465-A1 DIOXO-IMIDAZOLIDINE DERIVATIVES, WHICH INHIBIT THE ENZYME SOAT-1, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM GALDERMA RESEARCH & DEVELOPMENT (FR) 2010-09-02 WO disclosed